Network Pharmacology and Experimental Validation of the Ameliorative Effect of
Rosa rugosa
Essential Oil on Scopolamine‐Induced Cognitive Dysfunction in Mice
Sep 2026· Flavour and Fragrance Journal· 0 citations· 38 references
TL;DR
Animal experiments demonstrated that RrEO improved cognitive behaviour in mice, reduced central cholinergic neuronal damage and oxidative stress in the brain, increased the levels of monoamine neurotransmitters dopamine and 5‐hydroxytryptamine (5‐HT), preserved neuronal cell structure, and decreased cell apoptosis.
Abstract
In this study, common targets of Alzheimer's disease (AD) and the main components of
Rosa rugosa
essential oil (RrEO) were collected from databases including GeneCards, PubChem and STRING. Protein–protein interaction (PPI) networks were constructed, followed by GO functional enrichment analysis and KEGG pathway enrichment analysis using DAVID and Metascape databases. The enrichment results were further validated in a scopolamine (SCO)‐induced cognitive impairment mouse model through olfactory inhalation administration of RrEO. Network pharmacology analysis revealed 201 potential therapeutic targets of RrEO, among which AKT1, TNF, and BCL2 were identified as core targets, closely associated with oxidative stress, neuronal and lipid metabolism, brain neurotransmitter systems, and cytoprotection. Animal experiments demonstrated that RrEO improved cognitive behaviour in mice, reduced central cholinergic neuronal damage and oxidative stress in the brain, increased the levels of monoamine neurotransmitters dopamine and 5‐hydroxytryptamine (5‐HT), preserved neuronal cell structure, and decreased cell apoptosis. These experimental findings further corroborated the results obtained from the network pharmacology analysis of RrEO.
Chronic sleep deprivation (CSD) is currently a serious global public health concern, and CSD induces numerous diseases, including cognitive impairment. Bornyl acetate (BA) possesses a brilliant anti-inflammatory activity and plays a favorable role in neuroinflammation. The purpose of this research was to explore the ef...
Qing Lv, Mei-Ya Zhang, Rui-Ling Sun et al.· Scientific Reports· 0 citations
Findings position SRR as a hypothesis‐generating source of multi‐target candidate molecules and provide a prioritized framework for experimental validation in AD.
Archna Singh, Avijit Mazumder, A. Kanda· ChemistrySelect· 0 citations
Its favorable binding characteristics, electronic stability, and predicted brain permeability highlight apigenin as a potential candidate for the prevention and treatment of neurodegenerative diseases, warranting further experimental and clinical validation.
Betulin (BE) is extracted from pentacyclic triterpenoids of many natural plants and has antioxidation activities. However, the neuroprotective effects and underlying mechanism of Betulin in Alzheimer's disease (AD) have remained limited. Integrate SuperPred, SEA, and Targeted Net databases, as well as KEGG pathway enri...
Cong-Hui Dai, Yao Yang, Xia-Oou Lin et al.· Journal of Nutritional Bioch...· 0 citations
Background/Objectives: Diabetic Cognitive Impairment (DCI) involves cognitive impairment resulting from diabetes-triggered metabolic abnormalities and neuroinflammation; however, the therapeutic mechanisms of Xiaochaihu-tang (XCHT) remain unclear. Methods: This study systematically explored the potential pharmacologica...
B. Joo, Dong-Uk Kim, Bitna Kweon et al.· Brain Science· 0 citations